DCP1A
mRNA-decapping enzyme 1A
Also known as: DCP1A_HUMAN, HSA275986, SMAD4IP1, SMIF
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NPI6
- Gene
- DCP1A
- Ensembl
- ENSG00000272886
- Chromosome
- 3
- Canonical length
- 582 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters
- Subcellular location
- Cytoplasmic bodies
OverviewNCBI Gene
Decapping is a key step in general and regulated mRNA decay. The protein encoded by this gene is a decapping enzyme. This protein and another decapping enzyme form a decapping complex, which interacts with the nonsense-mediated decay factor hUpf1 and may be recruited to mRNAs containing premature termination codons. This protein also participates in the TGF-beta signaling pathway. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Feb 2014]
Canonical amino-acid sequenceUniProt
582 residues, UniProt reviewed canonical sequence.
>Q9NPI6|DCP1A
1 MEALSRAGQE MSLAALKQHD PYITSIADLT GQVALYTFCP KANQWEKTDI EGTLFVYRRS
61 ASPYHGFTIV NRLNMHNLVE PVNKDLEFQL HEPFLLYRNA SLSIYSIWFY DKNDCHRIAK
121 LMADVVEEET RRSQQAARDK QSPSQANGCS DHRPIDILEM LSRAKDEYER NQMGDSNISS
181 PGLQPSTQLS NLGSTETLEE MPSGSQDKSA PSGHKHLTVE ELFGTSLPKE QPAVVGLDSE
241 EMERLPGDAS QKEPNSFLPF PFEQLGGAPQ SETLGVPSAA HHSVQPEITT PVLITPASIT
301 QSNEKHAPTY TIPLSPVLSP TLPAEAPTAQ VPPSLPRNST MMQAVKTTPR QRSPLLNQPV
361 PELSHASLIA NQSPFRAPLN VTNTAGTSLP SVDLLQKLRL TPQHDQIQTQ PLGKGAMVAS
421 FSPAAGQLAT PESFIEPPSK TAAARVAASA SLSNMVLAPL QSMQQNQDPE VFVQPKVLSS
481 AIPVAGAPLV TATTTAVSSV LLAPSVFQQT VTRSSDLERK ASSPSPLTIG TPESQRKPSI
541 ILSKSQLQDT LIHLIKNDSS FLSTLHEVYL QVLTKNKDNH NLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DCP1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 28 nTPM
- thymus: 13 nTPM
- ovary: 12 nTPM
- endometrium: 11 nTPM
- cerebellum: 10 nTPM
- parathyroid gland: 9.7 nTPM
Single-cell type
- neutrophils: 201 nCPM
- sertoli cells: 171 nCPM
- adrenal cortex cells: 155 nCPM
- myonuclei: 134 nCPM
- extravillous trophoblasts: 132 nCPM
- neutrophil progenitors: 129 nCPM
Immune cell
- NK-cell: 55 nTPM
- non-classical monocyte: 53 nTPM
- MAIT T-cell: 51 nTPM
- naive CD4 T-cell: 50 nTPM
- naive B-cell: 49 nTPM
- memory CD8 T-cell: 48 nTPM
Brain region
- cerebellum: 30 nTPM
- cerebral cortex: 20 nTPM
- white matter: 19 nTPM
- choroid plexus: 18 nTPM
- thalamus: 18 nTPM
- pons: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.69
- gnomAD missense Z
- 1.21
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- deadenylation-dependent decapping of nuclear-transcribed mRNA
- deadenylation-independent decapping of nuclear-transcribed mRNA
- mRNA methylguanosine-cap decapping
- nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
- protein localization to cytoplasmic stress granule
Molecular functions
- 5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] hydrolase activity
- enzyme activator activity
- identical protein binding
- kinesin binding
- mRNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DCP1A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DCP1A as an antibody target. Whether an autoantibody or antibody against DCP1A could matter depends on whether native DCP1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DCP1A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DCP1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...